Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.420
+0.140 (6.14%)
Mar 4, 2026, 2:40 PM EST - Market open
Century Therapeutics Revenue
Century Therapeutics had revenue of $113.34M in the twelve months ending September 30, 2025, up 4,122.69% year-over-year. In the year 2024, Century Therapeutics had annual revenue of $6.59M with 194.81% growth.
Revenue (ttm)
$113.34M
Revenue Growth
+4,122.69%
P/S Ratio
3.82
Revenue / Employee
$755,580
Employees
150
Market Cap
434.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.59M | 4.35M | 194.81% |
| Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
| Dec 31, 2022 | 5.20M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 170.16M |
| Niagen Bioscience | 124.71M |
| Bicycle Therapeutics | 28.34M |
| Entrada Therapeutics | 25.42M |
| PureTech Health | 6.39M |
| Immutep | 5.28M |
| Armata Pharmaceuticals | 5.05M |
| Upstream Bio | 2.80M |
IPSC News
- 7 days ago - Century Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 16 days ago - IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewsWire
- 23 days ago - Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
- 3 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 5 months ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire